David P. Geaney

Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment

Jonathan Williams, Nigel Wellman, David P. Geaney et al. · The British Journal of Psychiatry · 1998 · 126 citations

Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes

David P. Geaney, Michael Schächter, Jonathan Elliot et al. · European Journal of Pharmacology · 1984 · 90 citations

5-Hydroxytryptamine Receptor, Drug Analysis, Biochemistry +6

Haloperidol enhances latent inhibition in visual tasks in healthy people

J. H. Williams, Nigel Wellman, David P. Geaney et al. · Psychopharmacology · 1997 · 72 citations

Cognitive Science, Latent Inhibition, Brain Function +8

Antipsychotic drug effects in a model of schizophrenic attentional disorder: A randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people

Jonathan Williams, Nigel Wellman, David P. Geaney et al. · Biological Psychiatry · 1996 · 62 citations

Healthy People, Latent Inhibition, Psychiatry +9

Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia

David P. Geaney, Peter Ellis, Nigel Soper et al. · Biological Psychiatry · 1992 · 16 citations

Psychiatry, Psychotropic Medication, Psychopharmacology +10